CLINICAL_TRIALS
trial_result
· 2024-08-30
Clinical Trial Update: Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine [Phase 4]
Summary
Phase 4 study updating the efficacy of erenumab (Aimovig) for high-frequency and episodic migraine has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2024-08-30